ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025

An executive at ANI Pharmaceuticals reported the sale of 4,772 shares on March 11, 2026 for a transaction value of $357,000, at a reported price of $74.91 per share. This sale represented 10.97% of Rowland Thomas Andrew's direct common stock holdings, reducing direct ownership to 38,730 shares post-transaction.